• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
After-effects reported by women having follow-up cervical cytology tests in primary care: a cohort study within the TOMBOLA trial.初级保健中进行宫颈细胞学随访检测的女性的不良反应报告:TOMBOLA 试验中的队列研究。
Br J Gen Pract. 2011 Jun;61(587):e333-9. doi: 10.3399/bjgp11X578007.
2
After-effects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial.阴道镜检查、宫颈活检和 LLETZ 术后女性报告的后遗症:TOMBOLA 试验的结果。
BJOG. 2009 Oct;116(11):1506-14. doi: 10.1111/j.1471-0528.2009.02263.x. Epub 2009 Jul 7.
3
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.英格兰原发性人乳头瘤病毒子宫颈筛查的临床效果和成本效益:通过三轮筛查对 ARTISTIC 随机试验队列进行的扩展随访。
Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.
4
Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial.活检及选择性召回与直接大环形切除术在处理因宫颈细胞学低度异常而转诊行阴道镜检查的女性中的比较:多中心随机对照试验
BMJ. 2009 Jul 28;339:b2548. doi: 10.1136/bmj.b2548.
5
HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.HPV 检测与常规细胞学检查在宫颈癌筛查中的比较:ARTISTIC RCT 的长期随访。
Health Technol Assess. 2019 Jun;23(28):1-44. doi: 10.3310/hta23280.
6
The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.IMproving Primary Screening And Colposcopy Triage 试验:人乳头瘤病毒、宫颈细胞学和组织病理学结果,来自基线和 1 年随访阶段。
Am J Obstet Gynecol. 2021 Sep;225(3):278.e1-278.e16. doi: 10.1016/j.ajog.2021.03.047. Epub 2021 Apr 20.
7
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.HPV 检测在宫颈癌筛查中的效果:四项欧洲随机对照试验的随访研究。
Lancet. 2014 Feb 8;383(9916):524-32. doi: 10.1016/S0140-6736(13)62218-7. Epub 2013 Nov 3.
8
Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA).低级别异常宫颈细胞学女性行阴道镜检查后心理困扰的相关因素:TOMBOLA 试验中一项关于边界型和其他低级别异常细胞学涂片管理的前瞻性研究。
Psychooncology. 2013 Feb;22(2):368-80. doi: 10.1002/pon.2097. Epub 2011 Dec 12.
9
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.HPV 焦点随机临床试验:48 个月时,用初级宫颈 HPV 检测与细胞学检测筛查对高级别宫颈上皮内瘤变的影响。
JAMA. 2018 Jul 3;320(1):43-52. doi: 10.1001/jama.2018.7464.
10
Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.人乳头瘤病毒(HPV)DNA检测联合细胞学分流和/或重复HPV DNA检测在原发性宫颈癌筛查中的效能
J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13.

引用本文的文献

1
Clinical application of DNA ploidy to cervical cancer screening: A review.DNA倍体在宫颈癌筛查中的临床应用:综述
World J Clin Oncol. 2014 Dec 10;5(5):931-65. doi: 10.5306/wjco.v5.i5.931.
2
Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the TOMBOLA randomised controlled trial.低度宫颈异常替代管理策略的社会心理影响:TOMBOLA随机对照试验的结果
PLoS One. 2013 Dec 30;8(12):e80092. doi: 10.1371/journal.pone.0080092. eCollection 2013.

本文引用的文献

1
Which women default from follow-up cervical cytology tests? A cohort study within the TOMBOLA trial.哪些女性未进行后续宫颈细胞学检查?TOMBOLA试验中的一项队列研究。
Cytopathology. 2012 Jun;23(3):150-60. doi: 10.1111/j.1365-2303.2011.00848.x. Epub 2011 Mar 2.
2
Barriers to cervical cancer screening attendance in England: a population-based survey.英格兰地区宫颈癌筛查参与障碍的研究:一项基于人群的调查。
J Med Screen. 2009;16(4):199-204. doi: 10.1258/jms.2009.009073.
3
Knowledge, awareness, and attitudes of female sex workers toward HPV infection, cervical cancer, and cervical smears in Thailand.泰国女性性工作者对 HPV 感染、宫颈癌和宫颈抹片的知识、意识和态度。
Int J Gynaecol Obstet. 2009 Dec;107(3):216-9. doi: 10.1016/j.ijgo.2009.07.023. Epub 2009 Aug 28.
4
Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.细胞学监测与直接转诊阴道镜检查在低级别宫颈异常女性管理中的比较:多中心随机对照试验
BMJ. 2009 Jul 28;339:b2546. doi: 10.1136/bmj.b2546.
5
After-effects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial.阴道镜检查、宫颈活检和 LLETZ 术后女性报告的后遗症:TOMBOLA 试验的结果。
BJOG. 2009 Oct;116(11):1506-14. doi: 10.1111/j.1471-0528.2009.02263.x. Epub 2009 Jul 7.
6
Cervical cancer screening attitudes and beliefs of Malaysian women who have never had a pap smear: a qualitative study.从未接受过巴氏涂片检查的马来西亚女性对宫颈癌筛查的态度和信念:一项定性研究
Int J Behav Med. 2008;15(4):289-92. doi: 10.1080/10705500802365490.
7
Exploring older women's approaches to cervical cancer screening.探索老年女性的宫颈癌筛查方法。
Health Care Women Int. 2007 Nov-Dec;28(10):930-50. doi: 10.1080/07399330701615358.
8
How do women who choose not to participate in population-based cervical cancer screening reason about their decision?那些选择不参与基于人群的宫颈癌筛查的女性,她们对自己的决定有怎样的理由阐述?
Psychooncology. 2008 Jun;17(6):561-9. doi: 10.1002/pon.1270.
9
Enclosing a pen with a postal questionnaire can significantly increase the response rate.随邮政调查问卷附上一支笔可以显著提高回复率。
J Clin Epidemiol. 2006 Jul;59(7):747-54. doi: 10.1016/j.jclinepi.2005.10.014.
10
Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): Trial design.临界及其他低级别异常涂片管理试验(TOMBOLA):试验设计
Contemp Clin Trials. 2006 Oct;27(5):449-71. doi: 10.1016/j.cct.2006.04.001. Epub 2006 Apr 28.

初级保健中进行宫颈细胞学随访检测的女性的不良反应报告:TOMBOLA 试验中的队列研究。

After-effects reported by women having follow-up cervical cytology tests in primary care: a cohort study within the TOMBOLA trial.

机构信息

Institute of Applied Health Sciences, University of Aberdeen, Scotland, UK.

出版信息

Br J Gen Pract. 2011 Jun;61(587):e333-9. doi: 10.3399/bjgp11X578007.

DOI:10.3399/bjgp11X578007
PMID:21801512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3103696/
Abstract

BACKGROUND

Although it is recognised that some women experience pain or bleeding during a cervical cytology test, few studies have quantified physical after-effects of these tests.

AIM

To investigate the frequency, severity, and duration of after-effects in women undergoing follow-up cervical cytology tests, and to identify subgroups with higher frequencies in Grampian, Tayside, and Nottingham.

DESIGN

Cohort study nested with a multi-centre individually randomised controlled trial.

METHOD

The cohort included 1120 women, aged 20-59 years, with low-grade abnormal cervical cytology who completed a baseline sociodemographic questionnaire and had a follow-up cervical cytology test in primary care 6 months later. Six weeks after this test, women completed a postal questionnaire on pain, bleeding, and discharge experienced after the test, including duration and severity. The adjusted prevalence of each after-effect was computed using logistic regression.

RESULTS

A total of 884 women (79%) completed the after-effects questionnaire; 30% of women experienced one or more after-effect: 15% reported pain, 16% bleeding, and 7% discharge. The duration of discharge was ≤2 days for 66%, 3-6 days for 22%, and ≥7 days for 11% of women. Pain or bleeding lasted ≤2 days in more than 80% of women. Severe after-effects were reported by <1% of women. The prevalence of pain decreased with increasing age. Bleeding was more frequent among nulliparous women. Discharge was more common among oral contraceptive users.

CONCLUSION

Pain, bleeding, and discharge are not uncommon in women having follow-up cervical cytology tests. Informing women about possible after-effects could better prepare them and provide reassurance, thereby minimising potential non-adherence with follow-up or non-participation with screening in the future.

摘要

背景

尽管人们认识到一些妇女在宫颈细胞学检查中会感到疼痛或出血,但很少有研究对这些检查的身体后遗症进行量化。

目的

调查接受宫颈细胞学检查随访的妇女出现后遗症的频率、严重程度和持续时间,并确定在格兰扁、泰赛德和诺丁汉后遗症发生率较高的亚组。

设计

嵌套于多中心个体随机对照试验的队列研究。

方法

该队列包括 1120 名年龄在 20-59 岁之间、宫颈细胞学低度异常的妇女,她们完成了基线社会人口统计学问卷,并在 6 个月后在初级保健中进行了随访宫颈细胞学检查。在该检查后 6 周,妇女完成了一份关于检查后疼痛、出血和分泌物的邮寄问卷,包括持续时间和严重程度。使用逻辑回归计算每种后遗症的调整后患病率。

结果

共有 884 名妇女(79%)完成了后遗症问卷;30%的妇女经历了一种或多种后遗症:15%报告疼痛,16%报告出血,7%报告分泌物。分泌物持续时间≤2 天的妇女占 66%,3-6 天的占 22%,≥7 天的占 11%。超过 80%的妇女疼痛或出血持续时间≤2 天。<1%的妇女报告严重后遗症。疼痛的患病率随年龄的增加而降低。初产妇出血更为常见。口服避孕药使用者分泌物更为常见。

结论

在接受宫颈细胞学检查随访的妇女中,疼痛、出血和分泌物并不少见。告知妇女可能出现的后遗症可以更好地为她们做好准备,并提供安慰,从而最大限度地减少未来随访时潜在的不遵医行为或筛查时的不参与。